Akademisyen
TANSU YAMAZHAN
PROFESÖR
EGE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 153
- Proje 0
- Kitap 6
- Bildiri 98
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
24
Q2
20
Q3
29
Q4
30
WoS (JCR)
Q1
6
Q2
20
Q3
19
Q4
65
TR Index
61
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
1
Üst %10 makale
7
Ort. yüzdelik
53.1%
Üst %1 payı
1.0%
Üst %10 payı
6.7%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 31.8%
- 2025 Ceftaroline + Rifampin Versus Vancomycin + Rifampin in the Treatment of Methicillin-Resistant Staphylococcus aureus Meningitis in an Experimental Rabbit Model YÖKSİS SJR Q2 JCR Q3 OpenAlex 3.7%
- 2025 Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non‐Invasive Approach YÖKSİS SJR Q1 JCR Q2 OpenAlex 10.2%
- 2025 Diyabetik ayak enfeksiyonu ile takipli hastalarda HBV seroprevalansı YÖKSİS TR Index OpenAlex 13.7%
- 2024 Impact of the empirical therapy timing on the clinical progress of septic shock patients YÖKSİS SJR Q2 JCR Q3 OpenAlex 24.0%
- 2024 Assessment of Unwanted Side Effects of Vaccines in Cancer Patients: Where Do We Stand in Vaccination? Where Should Our Next Step Be? YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 61.7%
- 2024 Tenofovir disoproxil fumarate in the treatment of COVID-19: Evaluation of 78 patients YÖKSİS SJR Q3 JCR Q4
- 2024 Konsültasyonlarda Arka Sokaklar: Antibiyotik Kullanımına Bağlı Yan Etkiler YÖKSİS TR Index JCR Q4 OpenAlex 26.0%
- 2024 Latent Tuberculosis Infection Management in Solid Organ Transplantation Recipients: A National Snapshot YÖKSİS OpenAlex 86.8%
- 2024 Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19 Patients YÖKSİS OpenAlex 50.4%
- 2024 The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study YÖKSİS OpenAlex 64.6%
- 2024 NÖROSİFİLİZ: ÜÇ OLGU YÖKSİS TR Index OpenAlex 4.2%
- 2023 Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases YÖKSİS SJR Q1 JCR Q2 OpenAlex 30.0%
- 2023 Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey YÖKSİS OpenAlex 43.8%
- 2023 Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data YÖKSİS SJR Q4 JCR Q4 OpenAlex 61.2%
- 2023 Is Having Diabetic Foot Infection a Risk Factor for Hepatitis C? YÖKSİS TR Index JCR Q4 OpenAlex 51.8%
- 2023 Can We Accurately Assess Fibrosis in Chronic Hepatitis B Virus Patients? YÖKSİS SJR Q4 JCR Q4 OpenAlex 18.0%
- 2023 Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study YÖKSİS OpenAlex 54.5%
- 2022 Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment? YÖKSİS OpenAlex 38.1%
- 2022 Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 57.0%